For the Inventor, By the Inventor

Enter assignee name

Danvers, MA, United States of America

Marine Polymer Technologies, Inc.

USPTO Granted Patents = 39

% Expired Patents = 23.1

CIPO Patents = 4

EPO Patents = 12

Trademarks = 13

Forward Citations = 771

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Sergio Finkielsztein (38 out of 44 patents)

John N Vournakis (38 out of 45 patents)

Ernest R Pariser (13 out of 15 patents)

4. Mike Helton (12 out of 14 patents)

5. Marco Finkielsztein (3 out of 3 patents)

6. Giorgio Pietramaggiori (2 out of 2 patents)

7. Dennis Paul Orgill (2 out of 13 patents)

8. Sergio Finkielstein (1 out of 1 patent)

9. Marina V Demcheva (0 patent)

10. Ernst R Pariser (0 patent)

11. Sergio Finkeilsztein (0 patent)

12. Giorgio Pietramaggiori (0 patent)

13. Dennis P Orgill (0 patent)

14. Dennis P Orgill (0 patent)

15. Giorgio Pietramaggiori (0 patent)

Core Competencies:

Poly-N-acetylglucosamine

Hemostatic Compositions

Wound Healing

Vascular Compression

Anti-Bacterial Applications

Cell Therapy

Biocompatible Polymers

Therapeutic Regimens

Polymer Materials

Vascular Access

Nanofibers

39 patents: Sort by Forward Citations

1. 10765698 - Treatment of disease with poly-N-acetylglucosamine nanofibers (2020-09-08),

2. 10561677 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2020-02-18),

3. 10383971 - Hemostatic compositions and therapeutic regimens (2019-08-20),

4. 10252040 - Application of polymeric materials to screens to facilitate hemostasis and wound healing (2019-04-09),

5. 10206938 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2019-02-19),

6. 10206683 - Methods and apparatus for a manual vascular compression device (2019-02-19),

7. 9867625 - Methods and apparatus for a manual radial artery compression device (2018-01-16),

8. 9642871 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2017-05-09),

9. 9320653 - Hemostatic compositions and uses therefor (2016-04-26),

10. 9198928 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2015-12-01),

11. 9139664 - Hemostatic compositions and therapeutic regimens (2015-09-22),

12. 9139663 - Hemostatic compositions and therapeutic regimens (2015-09-22),

13. 8992453 - Vascular access preservation in hemodialysis patients (2015-03-31),

14. 8871247 - Hemostatic compositions and therapeutic regimens (2014-10-28),

15. 8859528 - Compositions and methods for modulation of vascular structure and/or function (2014-10-14),

Marine Polymer Technologies, Inc. is a biotechnology company based in Danvers, Massachusetts, specializing in the development of innovative medical products derived from marine sources. The company focuses on creating advanced biomaterials and drug delivery systems, leveraging its expertise in polysaccharide chemistry. With a commitment to enhancing patient care, Marine Polymer Technologies aims to address unmet medical needs through its research in regenerative medicine and therapeutic applications.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

39 Patents

#5 in Danvers, MA

#513 in Massachusetts

#8,810 in US

#17,413 in the World

Danvers, MA, United States of America

Marine Polymer Technologies, Inc.

Forward Citations = 771

8 inventors:

Sergio Finkielsztein (38 out of 44 patents)

John N Vournakis (38 out of 45 patents)

Ernest R Pariser (13 out of 15 patents)

4. Mike Helton (12 out of 14 patents)

5. Marco Finkielsztein (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…